1130-220 Brugada-type electrocardiographic pattern and ST-segment alternans in right precordial leads during percutaneous coronary intervention of the proximal right coronary artery  by Fujimoto, Naoki et al.
JACC March 3, 2004 ABSTRACTS - Cardiac Arrhythmias  137A
Cardiac Arrhythm
ias
line. The remaining 74 subject (31 males and 43 females), who had negative ECG at
baseline, received intravenous class 1 blocker (ajmaline 1mg/kg). The ECG was consid-
ered positive if the ST-segment in leads V1 and V2 (V3) was elevated >0.2 mV and
showed “coved”-type morphology before or after the infusion of ajmaline. The exons of
SCN5A were screened in the families using direct sequencing.
Results All 4 families had a mutation in SCN5A. The 16 subjects with positive ECG at
baseline had SCN5A Mutation. Of the 74 individuals who received ajmaline test there
were 29 positives and 45 negatives. Two positives did not have the mutation, and 7 nega-
tives had the mutation. All results on the ajmaline test are shown in the table. The Sensi-
tivity, specificity, and positive or negative predictive value of the test is 79.4%, 95.0%, and
93.1% or 84.4%, respectively.
(male/female).
Conclusion A specificity of 95% and a sensitivity of close to 80% indicate that the ajma-
line test is very valuable in the diagnosis of SCN5A carriers in families with Brugada syn-
drome. There are two false positives that raises an issue of a second gene in the family
or an iatrogenic false positive.
1130-219 Conus Branch Ischemia Provokes Brugada-Type ST- 
Segment Changes in Patients With Coronary Artery 
Disease
Masaru Yamaki, Takeshi Nishiura, Toru Kaji, Mitsuru Gima, Naoki Funayama, Katsumi 
Ohbori, Nobuyuki Sato, Yuichiro Kawamura, Naoyuki Hasebe, Kenjiro Kikuchi, Hokkaido 
Cardiovascular Hospital, Sapporo, Japan, Asahikawa Medical College, Asahikawa, 
Japan
Recently, the intriguing coexistence of vasospastic angina and Brugada syndrome have
been reported in some cases. However, the mechanistic relationship between Brugada
type ECG abnormalities and ischemia of the right ventricular outflow tract has not been
fully elucidated. Here we present four cases with coronary artery disease who presented
with ECG abnormalities induced by ischemia of the conus branch (CB) of the right coro-
nary artery. The twelve-lead ECGs at rest showed normal sinus rhythm in all cases. Sur-
prisingly, the saddle back-type ST segment elevation in leads V1-V3 was observed either
during the percutaneous transluminal angioplasty procedure of the proximal right coro-
nary artery or with an intracoronary ergonovine injection into the right coronary artery.
The coronary angiogram exhibited a total occlusion or 99% stenosis with a delay in the
CB and significant stenosis of the proximal right coronary artery in three cases and coro-
nary vasospasms of the CB and right coronary artery in the remaining case. These Bru-
gada-type ECG changes reversibly disappeared after cessation of the ischemia from the
CB lesion. In the fourth patient which had vasospasms of the right coronary artery,
remarkable coved-type ST segment elevation was also induced by the class IC antiar-
rhythmic agent, pilsicainide, suggesting a concealed form of Brugada syndrome. These
results suggest that the free wall of the right ventricular outflow tract supplied by the CB
plays a pivotal role in the genesis of the Brugada-type ECG changes, and the ischemia
from CB lesions, at least in part, contributes to the Brugada-type ST segment changes.
1130-220 Brugada-Type Electrocardiographic Pattern and ST-
Segment Alternans in Right Precordial Leads During 
Percutaneous Coronary Intervention of the Proximal 
Right Coronary Artery
Naoki Fujimoto, Chikaya Omichi, Takafumi Koji, Atsushi Kawasaki, Shigeki Kato, 
Atsunobu Kasai, National Mie Central Hospital, Hisai, Japan
Background: Brugada syndrome is characterized by a right bundle branch block pattern
and ST segment elevation in the right precordial leads. The Brugada-type electrocardio-
graphic (ECG) pattern can be observed in asymptmatic healthy patients (pts) or condi-
tions other than true Brugada syndrome. The mechanisms of Brugada-type ECG pattern
are not fully understood.
Methods: We performed percutaneous coronary intervention (PCI) of proximal right cor-
onary artery (RCA) for ischemic heart diseases in 12 pts. No significant stenosis was
observed in left coronary arteries in all pts. The ST changes were evaluated during PCI.
Angiographical changes were carefully observed from major branches of RCA to small
branches during PCI. We measured ST elevation in right precordial leads with class I
antiarrhythmic drug administration: pilsicainide 50 mg (pure sodium channel blocker)
after PCI. ST changes were compared with true Brugada syndrome (n=5).
Results: Brugada-type ECG was observed in 5 pts (42%) but not in 7 pts (58%) during
PCI of proximal RCA. All 5 pts who had Brugada-type ECG demonstrated ST segment
alternans from coved shape to saddle back shape during PCI. These ECG changes
returned to normal after PCI. These pts who had Brugada-type ECG with ST alternans
demonstrated selective small RV branch occlusion or vasospasm during PCI, which per-
fused RV anterior wall or RV outflow. However pts without Brugada-type ECG did not
show RV branch occlusion. The class I antiarrhythmic drug administration showed no sig-
nificant ST elevation both in pts with Brugada-type ECG and in pts without Brugada-type
ECG (0.70±0.54mv, vs 0.46±0.21mv, p=NS). There was a significant difference in ST
elevation between pts with Brugada-type ECG during PCI and pts with true Brugada syn-
drome. (0.70±0.54mv, vs 2.86±0.61mv, p<0.05)
Conclusions: The pts who had RV branch occlusion during PCI showed Brugada-type
ECG and ST alternans. Sodium channel impairment was not associated with these ECG
changes. ST alternans might be considered as prerequisites before developing ventricu-
lar arrhythmia. These data suggest that merely ischemia of small RV branch could be
one of the different entities showing Brugada-type ECG from true Brugada syndrome.
1130-221 Prior Ischemia Enhances Arrhythmogenicity in Isolated 
Canine Ventricular Wedge Model of Long QT 3
Norihiro Ueda, Douglas P. Zipes, Jiashin Wu, Krannert Institute of Cardiology, 
Indianapolis, IN
Background: Ventricular tachyarrhythmias (VTs) occur frequently in patients having long
QT syndrome (LQTS) or after acute myocardial ischemia. However, the synergistic
effects of ischemia and LQTS on arrhythmia development are unclear. We evaluated the
contribution of a prior episode of ischemia on the arrhythmogenicity of the LQTS. Meth-
ods : Using a 256-channel optical mapping system, we mapped action potentials on the
cut-exposed transmural surfaces of arterially perfused muscle wedges isolated from
canine left ventricular free walls and recorded their transmural electrocardiogram (ECG).
Results: We observed that 40 minutes of global ischemia (no perfusion) followed by 60
minutes of reperfusion, at which time action potential duration (APD) and conduction
velocity had recovered, significantly enhanced the APD prolongation produced by anem-
one toxin II (ATX-II, 20 nmol/L), which delays the inactivation of sodium current and pro-
duces type 3 LQTS. The combination of ischemia, reperfusion, and ATX-II caused early
afterdepolarization (EAD) development in 8/8 wedges (100%) and spontaneous VTs in 7/
8 wedges (87.5%) at a time when perfusion was normal. We observed epicardial, midmy-
ocardial, and endocardial occurrences of EADs in 1, 7, and 4 wedges, respectively. Focal
EAD and reentry were responsible for 73% and 18% of the repetitive activations in the
VTs. Reentry, transmural APD heterogeneity, and EADs originating from multiple focal
sites generated polymorphic VT in the transmural ECG. In contrast, neither EADs (0%)
nor VTs (0%) occurred in 8 control wedges having the same protocol except without
ischemia (ATX-II only), and VT occurred in 2/10 wedges (20%) after ischemia but before
ATX-II (ischemia only). Conclusions: A prior episode of acute ischemia, even after
apparent electrophysiologic recovery, enhances the arrhythmogenicity of LQTS induced
by ATX-II through the development of EADs and reentry. The results imply that patients
with both LQTS and ischemic heart disease or those with myocardial ischemia or infarc-
tion who take medications that prolong APD could be at increased risk for developing VT.
1130-222 High Incidence of Prolonged QTc in Asthmatics
Craig D. Williams, Richard J. Kovacs, Sandip Sheth, Cindy Calley, Purdue University 
School of Pharmacy, Indianapolis, IN, Indiana University School of Medicine, 
Indianapolis, IN
Background: A high incidence of asthma has been reported amoung registrants of the
International Long QT Syndrome (LQTS) Registry. Asthma is associated with a risk of
sudden death that is not always explained by pulmonary findings at autopsy.
Objective: To determine if a higher than expected rate of LQTS occurs in an identified
cohort of patients with asthma.
Methods: Patients over 18 years of age admitted to a city-county hospital with a primary
diagnosis of asthma between February 1, 2001 and September 30, 2002 were identified.
Patients with a documented ECG performed since December 2000 were enrolled. A sin-
gle cardiologist read all ECGs to determine the QT interval which was then corrected with
a Bazetts calculation to determine QTc. Lead II was used for QT interval measurement. If
lead II was unreadable, lead V5 or aVF was used. The reported, uncorrected QT interval
was an average of the measurement of three different complexes in the same lead. QTc
results were compared to a published cohort of 420 non-asthamtic adults. Prolonged
QTc was defined as > 455 msec in men and > 475 msec in women which defined the
upper 1% of QTc in the non-asthmatic cohort. No patients were on anti-psychotic or anti-
arrhythmic medications. Patients were excluded from analysis if they had a previous doc-
umented myocardial infarction (1 patient), or documented hypokalemia (2 patients),
hypocalcemia (1 patient), or hypomagnesemia (1 patient) within 1 week of their recorded
ECG.
Results: 193 patients were identified, 130 of whom had a readable ECG. The incidence
of prolonged QTc was 19.8% (17/86) in females, 28.2% (11/39) in males and 22.4% (28/
125) overall. Compared to the 1% incidence of prolonged QTc in the published non-asth-
matic cohort, a one sample test of proportions was statistically significant for all 3 data
sets (p< 0.001 for male, female and overall).
Conclusion: Asthmatics appear to have an unusually high incidence of prolonged QTc
intervals.
1130-223 Utility of Adenosine in Differentiation of Patients With 
Right Ventricular Outflow Tract Tachycardia and 
Arrhythmogenic Right Ventricular Dysplasia
Sei Iwai, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, Amit B. Guttigoli, Bindi 
K. Shah, Ravi K. Yarlagadda, Bruce B. Lerman, Cornell University Medical Center, New 
York, NY
Background: Patients with right ventricular outflow tract (RVOT) tachycardia and arrhyth-
mogenic right ventricular dysplasia (ARVD) can both present with left bundle branch
block inferior axis ventricular tachycardia (VT). However, the management and prognosis
of the two entities is very different, and clear differentiation of these etiologies of VT
would be clinically useful. Termination with adenosine is thought to be specific for arrhyth-
mias due to cyclic AMP-mediated triggered activity; adenosine, with rare exceptions, has
no effect on arrhythmias due to reentry. Methods and Results: We compared the sensi-
tivity of VT to adenosine in patients with RVOT tachycardia and those with ARVD. VT was
sensitive to adenosine in 35 of 40 patients with RVOT tachycardia. Of note, 2 of the 5 pts
with adenosine-insensitive VT were subsequently found to have a somatic mutation in
the inhibitory G-protein, Gi, impairing intracellular cyclic AMP regulation. In contrast, 10
of 10 patients with ARVD had VT which was adenosine-insensitive. Therefore, the sensi-
tivity of adenosine termination of VT in identifying pts with RVOT tachycardia was 88%
while the specificity was 100%. Conclusions: These findings suggest that response of
VT to adenosine may be a simple and effective clinical tool for differentiating patients with
RVOT tachycardia from those with VT due to ARVD.
